Home > Keywords > Thématique > Agenda

Agenda

Articles

  • Vect-Horus will be attending the EANM’18 Congress in Düsseldorf
    28 January 2019, by Jonathan NOWAK

    VECT-HORUS will present a poster on its proprietary technology platform, VECTrans®, for the targeting and delivery of imaging or therapeutic agents to tumors.
    Please come and meet Cedric MALICET PhD, Oncology Project Manager.

  • Vect-Horus at Pierre Fabre DayOne Open Innovation Day
    28 January 2019, by Jonathan NOWAK

    Vect-Horus selected for an elevator pitch during DAYONE 2017: an open innovation day dedicated to pharmaceutical innovation. The one day conference aim is to identify, bring out, and develop innovative projects by biopharmaceutical companies, start-ups, and research laboratories (public or private) specialized in oncology, dermatology or consumer healthcare.
    https://www.pierre-fabre.com/en/news/applications-dayone-2017-are-open-unique-open-innovation-day-dedicated-pharmaceutical

  • Meet Vect-Horus at BIO Spring Amsterdam
    28 January 2019, by Jonathan NOWAK

    VECT-HORUS will attend BIO Spring from 12-14 March 2018.
    If you are interested to meet, please use the B2B Partnering system or send an email to Elodie DORMES, Business Development Manager at elodie.dormes(at)vect-horus(dot)com
    https://ebdgroup.knect365.com/bioeurope-spring/

  • Meet Vect-Horus at BIO International
    26 May 2021, by Elodie DORMES

    Elodie DORMES will attend Bio International Convention in June 10-18, 2021.

  • Meet Vect-Horus at BIO Europe Cologne
    28 January 2019, by Jonathan NOWAK

    November 7-9 // Köln, GERMANY

  • Meet Vect-Horus at BIO International in Boston June 5-8, 2023
    5 June 2023, by Elodie DORMES

    Emmanuelle BETTENDORF, Sr Business Developer, will attend Bio International Convention.

  • Participation au BIOREZO™ Vectorisation : de l’imagerie à la thérapeutique
    28 January 2019, by Jonathan NOWAK

    Participation au BIOREZO™ VECTORISATION : DE L’IMAGERIE À LA THÉRAPEUTIQUE

  • Vect-Horus will be attending BIO Europe from the 24th - 26th October in Germany
    20 October 2022, by Elodie DORMES

    This is the first in person BIOEurope since 2019 and we are excited to meet everyone face-to-face again.
    Feel free to connect with Emmanuelle BETTENDORF on the platform for a meeting/coffee to discuss our DrugDelivery platform, amongt others in Neurodegenerative, Muscular, Cardiovascular and Eye diseases.

  • Meet Vect-Horus at BIOTECH SHOWCASE, San Francisco, January 8-10, 2024
    20 December 2023, by Emmanuelle BETTENDORF

    From January 8 to 10, Emmanuelle Bettendorf will participate in the #BiotechShowcase at #JPM24 and will be available to meet with you on partnership opportunities.

  • Vect-Horus Nominated for the 2024 Biotech Trophy Award, Organized by France Biotech
    21 March 2024, by Emmanuelle BETTENDORF

    Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has been nominated for the 2024 Biotech Trophy award, organized by the France Biotech industry association.
    The award recognizes a biotech company which has distinguished itself in the past two years by particularly remarkable advances in R&D, operational development, partnerships or (…)